How many insider trades does FilingIQ track for SVRA?

FilingIQ tracks 266 Form 4 insider transactions for SVRA (Savara Inc), covering filings from Jun 9, 2017 onwards. 2 of those are dated within the last 90 days.

Are SVRA insiders net buyers or net sellers?

Across the full Form 4 history for SVRA, 110 transactions (41%) were open-market purchases and 35 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SVRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is SVRA in?

Savara Inc (SVRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.18B.

SVRA insider trading

NasdaqGS Healthcare

Savara Inc: insider trade history from SEC Form 4 filings.

Total Form 4 trades

266

Last 90 days

Buys / sells

41% / 13%

Market cap

$1.18B

About Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Company website: www.savarapharma.com

SVRA insider activity at a glance

FilingIQ tracks 266 insider transactions for SVRA in filings since Jun 9, 2017. The most recent transaction is dated Sep 24, 2026.

Across the full history, 110 open-market purchases and 35 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SVRA insider trades is 55.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SVRA trades on FilingIQ Raw filings on SEC EDGAR

Latest SVRA Form 4 filings

Parker Braden C. Chief Commercial Officer

F Sep 25, 2026

Lutz Robert Matthew Chief Fin. & Operating Officer

A Jul 24, 2026

Lowrance David L Chief Financial Officer

SFM Jun 22, 2026

Lowrance David L Chief Financial Officer

Lowrance David L Chief Financial Officer

FG Dec 16, 2025

Pauls Matthew CHIEF EXECUTIVE OFFICER

FG Dec 16, 2025

Lutz Robert Matthew Chief Operating Officer

F Dec 16, 2025

McCabe Kathleen R. Chief Legal Officer

F Dec 16, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Top insiders trading SVRA

Lowrance David L

35 trades · score 78.0

Frequently asked

How many insider trades does FilingIQ track for SVRA?: FilingIQ tracks 266 Form 4 insider transactions for SVRA (Savara Inc), covering filings from Jun 9, 2017 onwards. 2 of those are dated within the last 90 days.
Are SVRA insiders net buyers or net sellers?: Across the full Form 4 history for SVRA, 110 transactions (41%) were open-market purchases and 35 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SVRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is SVRA in?: Savara Inc (SVRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.18B.

Methodology & sources

Every SVRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.